Quidel | QDEL - Net Income


Quidel reported $-92.9M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Abbott USD 928M 149M Jun/2026
Agilent USD 362M 23M Jun/2026
Becton, Dickinson and Co. USD 377M 688M Jun/2026
Bruker USD -62.9M 66.4M Jun/2026
Cerus USD -20.92M 17.98M Dec/2024
Charles River Laboratories USD -1.48M 13.36M Jun/2026
Danaher USD 870M 159M Jun/2026
Haemonetics USD 33.01M 53.16M Jun/2026
Illumina USD 207M 73M Jun/2026
IQVIA Holdings USD 256M 18M Jun/2026
Merit Medical Systems USD 41M 2.99M Mar/2026
Mettler Toledo International USD 232.9M 63.44M Jun/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
Neogen USD -11.3M 5.7M Mar/2026
OraSure Technologies USD -19.29M 5.57M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Quidel USD -92.9M 1.1M Jun/2026
Revvity USD 51.82M 11.1M Jun/2026
STAAR Surgical USD 8.06M 2.85M Jun/2026
Thermo Fisher Scientific USD 1.74B 85M Jun/2026
Waters USD -136M 64M Jun/2026